Literature DB >> 30671709

Effect of health disparities on overall survival of patients with glioblastoma.

Jacob J Mandel1, Michael Youssef1,2, Jooyeon Nam3, Akash J Patel1, Ali Jalali1, Ethan B Ludmir4, Diane Liu5, Jimin Wu5, Georgina Armstrong6, Jason Huse7, Melissa Bondy6, John F de Groot8.   

Abstract

BACKGROUND: Examine the potential effects of health disparities in survival of glioblastoma (GB) patients.
METHODS: We conducted a retrospective chart review of newly diagnosed GB patients from 2000 to 2015 at a free standing dedicated cancer center (MD Anderson Cancer Center-MDACC) and a safety net county hospital (Ben Taub General Hospital-BT) located in Houston, Texas. We obtained demographics, insurance status, extent of resection, treatments, and other known prognostic variables (Karnofsky Score-KPS) to evaluate their role on overall GB survival (OS).
RESULTS: We identified 1073 GB patients consisting of 177 from BT and 896 from MDACC. We found significant differences by ethnicity, insurance status, KPS at diagnosis, extent of resection, and percentage of patients receiving standard of care (SOC) between the two centers. OS was 1.64 years for MDACC patients and 1.24 years for BT patients (p < 0.0176). Only 81 (45.8%) BT patients received SOC compared to 577 (64%) of MDACC patients (p < 0.0001). However, there was no significant difference in OS for patients who received SOC, 1.84 years for MDACC patients and 1.99 years for BT patients (p < 0.4787). Of the 96 BT patients who did not receive SOC, 29 (30%) had KPS less than 70 at time of diagnosis and 77 (80%) lacked insurance.
CONCLUSIONS: GB patients treated at a safety net county hospital had similar OS compared to a free standing comprehensive cancer center when receiving SOC. County hospital patients had poorer KPS at diagnosis and were often lacking health insurance affecting their ability to receive SOC.

Entities:  

Keywords:  Glioblastoma; Health disparities; Insurance; Overall survival; Race

Mesh:

Year:  2019        PMID: 30671709     DOI: 10.1007/s11060-019-03108-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  5 in total

1.  Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI).

Authors:  Krissia M Rivera Perla; Oliver Y Tang; Shayla N M Durfey; Tito Vivas-Buitrago; Wendy J Sherman; Ian Parney; Joon H Uhm; Alyx B Porter; Heinrich Elinzano; Steven A Toms; Alfredo Quiñones-Hinojosa
Journal:  J Neurooncol       Date:  2022-05-03       Impact factor: 4.130

2.  Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US.

Authors:  Quinn T Ostrom; Halle L Krebs; Nirav Patil; Gino Cioffi; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2021-03-23       Impact factor: 4.130

3.  The impact of hospital safety-net status on inpatient outcomes for brain tumor craniotomy: a 10-year nationwide analysis.

Authors:  Oliver Y Tang; Krissia M Rivera Perla; Rachel K Lim; Robert J Weil; Steven A Toms
Journal:  Neurooncol Adv       Date:  2020-12-01

4.  Identifying Disparities in Care in Treating Glioblastoma: A Retrospective Cohort Study of Patients Treated at a Safety-net Versus Private Hospital Setting.

Authors:  Theodore Wang; Anthony Pham; Stella Yoo; Frank J Attenello; Richard Jennelle; Naveed Wagle; Eric L Chang; Gabriel Zada
Journal:  World Neurosurg       Date:  2020-01-27       Impact factor: 2.104

5.  Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.

Authors:  Quinn T Ostrom; Gabrielle Truitt; Haley Gittleman; Daniel J Brat; Carol Kruchko; Reda Wilson; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2019-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.